Alizapride

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Alizapride
Alizapride.svg
3D Alizapride.png
Systematic (IUPAC) name
N-[(1-allylpyrrolidin-2-yl)methyl]-6-methoxy-1H-benzo[d][1,2,3]triazole-5-carboxamide
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
  • Prescription only
Routes Oral, IM, IV
Pharmacokinetic data
Half-life 3 hours
Excretion Renal
Identifiers
CAS number 59338-93-1 YesY
ATC code A03FA05
PubChem CID 43008
DrugBank DB01425
ChemSpider 39202 YesY
UNII P55703ZRZY YesY
KEGG D07102 YesY
ChEMBL CHEMBL290194 YesY
Chemical data
Formula C16H21N5O2 
Mol. mass 315.37 g/mol
 YesY (what is this?)  (verify)

Alizapride (Litican, Plitican, Superan, Vergentan) is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide and other benzamides.[1]

See also[edit]

Alizapride synthesis.png

Anon., Drugs Future 1981, 6, 11.

References[edit]

  1. ^ Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M (1988). "Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial". Cancer Chemother Pharmacol 22 (4): 316–20. doi:10.1007/bf00254238. PMID 3048762.